跳至主要内容
临床试验/NCT01487746
NCT01487746Unknown不适用

Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls.

Meir Medical Center1 个研究点 分布在 1 个国家目标入组 207 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
207
试验地点
1

研究概览

简要总结

The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies.

The investigators believe that minor antibodies have a major role in the hypercoagulability state.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • stroke diagnosis
  • blood sampling within 36hrs from the event
  • written agreement

排除标准

  • a stroke, MI or major operation prior to the current stroke
  • hypercoagulable state known in this patient
  • a severe chronic disease known at the time of the stroke
  • an infection on arrival (based on anamnesis, physical exam and lab tests)
  • thrombolytic treatment

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验